Stabilization device, system, and methods thereof for integrated catheters

Information

  • Patent Grant
  • 12239803
  • Patent Number
    12,239,803
  • Date Filed
    Monday, August 29, 2022
    3 years ago
  • Date Issued
    Tuesday, March 4, 2025
    9 months ago
Abstract
A stabilization device for integrated catheters can include a platform, a pair of catheter fasteners on the platform, and a pair of stabilization wings extending from the platform. The platform can include a skin-facing side and catheter-securing side of the platform. The pair of catheter fasteners can be on the catheter-securing side of the platform. The catheter fasteners can be configured to secure a hub of an integrated catheter having an extension port. The pair of stabilization wings can extend from a transverse axis of the platform. The stabilization wings can be configured to mitigate rotation of the integrated catheter about a longitudinal axis thereof when the integrated catheter is secured by the catheter fasteners on the platform and the stabilization device is adhered to a patient. A method for stabilizing integrated catheters can include securing an integrated catheter and adhering the stabilization device to a patient's skin.
Description
BACKGROUND

A peripheral intravenous catheter (“PIVC”) often needs to be prematurely removed from a patient before an intended IV therapy is complete. A primary factor contributing to the need to prematurely remove a PIVC is mechanical phlebitis, which results when the PIVC moves and irritates the internal anatomy of the patient. A secondary factor contributing to the need to prematurely remove a PIVC is potential introduction of microorganisms when the PIVC moves while within the patient. Mechanical stabilization of PIVCs has been shown to decrease mechanical phlebitis and increase IV-therapy dwell time. However, existing stabilization devices for such PIVCs are not compatible with integrated PIVCs. Thus, the existing stabilization devices cannot provide the mechanical stabilization needed to reduce mechanical phlebitis and enhance the dwell time needed to complete intended IV therapies with integrated PIVCs. Disclosed herein is a stabilization device and methods thereof for integrated catheters such as integrated PIVCs.


SUMMARY

Disclosed herein is a stabilization device for integrated catheters including, in some embodiments, a platform, a pair of catheter fasteners on the platform, and a pair of stabilization wings extending from the platform. The platform has a skin-facing side and catheter-securing side of the platform. The pair of catheter fasteners is on the catheter-securing side of the platform. The catheter fasteners are configured to secure a hub of an integrated catheter having an extension port. The pair of stabilization wings extend from a transverse axis of the platform. The stabilization wings are configured to mitigate rotation of the integrated catheter about a longitudinal axis thereof when the integrated catheter is secured by the catheter fasteners on the platform and the stabilization device is adhered to a patient.


In some embodiments, the platform is configured with a degree of flexibility enabling the platform to conform to a contour of the patient at a stabilization site thereof.


In some embodiments, the skin-facing side of the platform has an adhesive thereon configured to adhere to skin of the patient.


In some embodiments, the stabilization device further includes a pad of a foam-like material having a skin-facing side and a platform-facing side of the pad. The pad is configured with a degree of compressibility enabling the pad to conform to a contour of the patient at a stabilization site thereof.


In some embodiments, the skin-facing side of the pad has an adhesive thereon configured to adhere to skin of the patient.


In some embodiments, the catheter fasteners are spaced apart from each other to accommodate the extension port of the integrated catheter between the catheter fasteners when the integrated catheter is secured by the catheter fasteners on the platform.


In some embodiments, at least one catheter fastener of the pair of catheter fasteners is a ‘C’-shaped clip connected to the catheter-securing side of the platform.


In some embodiments, at least one catheter fastener of the pair of catheter fasteners is a clamp having a first jaw connected to the catheter-securing side of the platform and a second jaw connected to the first jaw by a living hinge.


In some embodiments, the platform includes a plurality of through holes configured to enable moisture between the stabilization device and the patient to escape through the through holes when the stabilization device is adhered to the patient.


In some embodiments, the transverse axis of the platform is an axis of symmetry of the platform.


Also disclosed herein is a stabilization device for integrated catheters including, in some embodiments, a platform, a pair of catheter fasteners on the platform, and a pair of stabilization wings extending from the platform. The platform is a polymer-based platform having a skin-facing side and catheter-securing side of the platform. The pair of catheter fasteners is on the catheter-securing side of the platform. The catheter fasteners are configured to secure a hub of an integrated catheter having an extension port. The pair of stabilization wings extend from a transverse axis of the platform. The stabilization wings are configured to mitigate rotation of the integrated catheter about a longitudinal axis thereof when the integrated catheter is secured by the catheter fasteners on the platform and the stabilization device is adhered to a patient. The platform having twofold symmetry about the transverse axis of the platform.


In some embodiments, the platform is configured with a degree of flexibility enabling the platform to conform to a contour of the patient at a stabilization site thereof. The skin-facing side of the platform has an adhesive thereon configured to adhere to skin of the patient.


In some embodiments, the stabilization device further includes a pad of a foam-like material having a skin-facing side and a platform-facing side of the pad. The pad is configured with a degree of compressibility enabling the pad to conform to a contour of the patient at a stabilization site thereof. The skin-facing side of the pad has an adhesive thereon configured to adhere to skin of the patient.


In some embodiments, the catheter fasteners are spaced apart from each other to accommodate the extension port of the integrated catheter between the catheter fasteners when the integrated catheter is secured by the catheter fasteners on the platform.


In some embodiments, at least one catheter fastener of the pair of catheter fasteners is a ‘C’-shaped clip connected to the catheter-securing side of the platform. The ‘C’-shaped clip is configured with a degree of flexibility enabling an opening of the ‘C’-shaped clip to initially expand when the hub of the integrated catheter is inserted into the opening and subsequently contract when the hub of the integrated catheter is inserted past the opening.


In some embodiments, at least one catheter fastener of the pair of catheter fasteners is a clamp having a first jaw connected to the catheter-securing side of the platform and a second jaw connected to the first jaw by a living hinge. The clamp is configured with a snap between the first jaw and the second jaw configured to snap the first and second jaws together after the hub of the integrated catheter is inserted into the clamp.


In some embodiments, the platform includes a plurality of through holes configured to enable moisture between the stabilization device and the patient to escape through the through holes when the stabilization device is adhered to the patient.


Also disclosed herein is a method for stabilizing integrated catheters including, in some embodiments, securing a hub of an integrated catheter in a pair of catheter fasteners on a catheter-securing side of a platform of a stabilization device, the catheter fasteners spaced apart from each other to accommodate an extension port of the integrated catheter between the catheter fasteners; removing an adhesive backing from a skin-facing side of the stabilization device to expose an adhesive; and adhering the stabilization device to skin at a stabilization site near a percutaneous insertion site of a patient, thereby stabilizing the integrated catheter and decreasing risk of mechanical phlebitis.


In some embodiments, securing the hub of the integrated catheter in the pair of catheter fasteners includes expanding an opening of at least one ‘C’-shaped clip of the pair of catheter fasteners upon inserting the hub into the ‘C’-shaped clip and allowing the opening of the ‘C’-shaped clip to contract upon inserting the hub past the opening of the of the ‘C’-shaped clip.


In some embodiments, securing the hub of the integrated catheter in the pair of catheter fasteners includes enclosing the hub within at least one clamp of the pair of catheter fasteners and snapping the clamp closed around the hub. The clamp has a first jaw connected to the catheter-securing side of the platform and a second jaw connected to the first jaw by a living hinge.


In some embodiments, the methods further includes degreasing the patient's skin at the stabilization site with a degreasing wipe before adhering the platform to the skin of the patient.


These and other features of the concepts provided herein will become more apparent to those of skill in the art in view of the accompanying drawings and following description, which disclose particular embodiments of such concepts in greater detail.





DRAWINGS


FIG. 1 illustrates a stabilization device for integrated catheters including an integrated catheter in accordance with some embodiments.



FIG. 2 illustrates a stabilization device including a ‘C’-shaped clip for a catheter fastener in accordance with some embodiments.



FIG. 3 illustrates a stabilization device including a clamp for a catheter fastener in accordance with some embodiments.



FIG. 4 illustrates a first platform for a stabilization device in accordance with some embodiments.



FIG. 5 illustrates a second platform for a stabilization device in accordance with some embodiments.



FIG. 6 illustrates a third platform for a stabilization device in accordance with some embodiments.



FIG. 7 illustrates a stabilization device including the platform of FIG. 5 in accordance with some embodiments.



FIG. 8 illustrates a stabilization device including the platform of FIG. 6 in accordance with some embodiments.





DESCRIPTION

Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.


With respect to terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.


With respect to “integrated catheter,” an integrated catheter is a one-piece manufacturer-assembled device including a catheter tube fluidly connected to at least one extension tube by way of a hub therebetween. Such an integrated catheter is shown in FIG. 1 by way of integrated catheter 10, which includes a catheter tube 12, a hub 14, an extension port 16 extending from the hub 14, and an extension tube 18 connected to the extension port 16. An integrated catheter is different than a non-integrated catheter, which must be assembled by a clinician or the like prior to use.


With respect to “proximal,” as in a “proximal portion” or a “proximal end portion” of, for example, a catheter disclosed herein, “proximal” refers to a portion of the catheter intended to be near a clinician when the catheter is used on a patient. Likewise, a “proximal length” of, for example, the catheter includes a length of the catheter intended to be near the clinician when the catheter is used on the patient. A “proximal end” of, for example, the catheter includes an end of the catheter intended to be near the clinician when the catheter is used on the patient. The proximal portion, the proximal end portion, or the proximal length of the catheter can include the proximal end of the catheter; however, the proximal portion, the proximal end portion, or the proximal length of the catheter need not include the proximal end of the catheter. That is, unless context suggests otherwise, the proximal portion, the proximal end portion, or the proximal length of the catheter is not a terminal portion or terminal length of the catheter.


With respect to “distal,” as in a “distal portion” or a “distal end portion” of, for example, a catheter disclosed herein, “distal” refers to a portion of the catheter intended to be near or in a patient when the catheter is used on the patient. Likewise, a “distal length” of, for example, the catheter includes a length of the catheter intended to be near or in the patient when the catheter is used on the patient. A “distal end” of, for example, the catheter includes an end of the catheter intended to be near or in the patient when the catheter is used on the patient. The distal portion, the distal end portion, or the distal length of the catheter can include the distal end of the catheter; however, the distal portion, the distal end portion, or the distal length of the catheter need not include the distal end of the catheter. That is, unless context suggests otherwise, the distal portion, the distal end portion, or the distal length of the catheter is not a terminal portion or terminal length of the catheter.


Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.


Again, a PIVC often needs to be prematurely removed from a patient before an intended IV therapy is complete. A primary factor contributing to the need to prematurely remove a PIVC is mechanical phlebitis, which results when the PIVC moves and irritates the internal anatomy of the patient. A secondary factor contributing to the need to prematurely remove a PIVC is potential introduction of microorganisms when the PIVC moves while within the patient. Mechanical stabilization of PIVCs has been shown to decrease mechanical phlebitis and increase IV-therapy dwell time. However, existing stabilization devices for such PIVCs are not compatible with integrated PIVCs. Thus, the existing stabilization devices cannot provide the mechanical stabilization needed to reduce mechanical phlebitis and enhance the dwell time needed to complete intended IV therapies with integrated PIVCs. Disclosed herein is a stabilization device and methods thereof for integrated catheters such as integrated PIVCs.


For example, a stabilization device for integrated catheters is disclosed including, in some embodiments, a platform, a pair of catheter fasteners on the platform, and a pair of stabilization wings extending from the platform. The platform has a skin-facing side and catheter-securing side of the platform. The pair of catheter fasteners is on the catheter-securing side of the platform. The catheter fasteners are configured to secure a hub of an integrated catheter having an extension port. The pair of stabilization wings extend from a transverse axis of the platform. The stabilization wings are configured to mitigate rotation of the integrated catheter about a longitudinal axis thereof when the integrated catheter is secured by the catheter fasteners on the platform and the stabilization device is adhered to a patient. Also, a method for stabilizing integrated catheters with the stabilization device is disclosed.


Stabilization Device



FIG. 1 illustrates a stabilization device 100 for integrated catheters such as the integrated catheter 10 in accordance with some embodiments.


As shown in FIG. 1, some embodiments of the stabilization device 100 include a platform 110, a pair of catheter fasteners 120 on the platform 110, and a pair of stabilization wings 130 extending from the platform 110. The stabilization device 100, or the platform 110 thereof, has a skin-facing side 102 and catheter-securing side 104. The pair of catheter fasteners 120 is on the catheter-securing side 104 of the platform 110. The catheter fasteners 120 are configured to secure the hub 14 of the integrated catheter 10 with (or without) the extension port 16. As shown and described in more detail below with reference to FIGS. 4-6, the pair of stabilization wings 130 extend from a transverse axis 412 of the platform 110. The stabilization wings 130, which are shown as sweeping back from a distal end portion to a proximal end portion of the stabilization device 100, are configured to mitigate rotation of the integrated catheter 10 about a longitudinal axis thereof when both the integrated catheter 10 is secured by the catheter fasteners 120 on the platform 110 and the stabilization device 100 is adhered to a patient.


Also shown in FIG. 1, some embodiments of the stabilization device 100 also include a pad 130 adhered to the platform 110 and an adhesive backing 140 with optional wings 142 configured to facilitate removal of the adhesive backing from the pad 130 (or the platform 110, or the like, in some embodiments) for adhering the stabilization device 100 to a patient at a stabilization site thereof.


For expository expediency, “the stabilization device 100” of FIG. 1 is sometimes used herein to generically refer to some or all of the disclosed stabilization devices. In such instances, a certain component (e.g., “the platform 110”) of the stabilization device 100 is sometimes used herein to generically refer to some or all of the disclosed stabilization-device components of the same kind. Because the stabilization device 100 and the components thereof can have unique features (e.g., the height h1 of the platform 110 is greater than the height h2 of the platform 510), context determines how “the stabilization device 100” and the components thereof are used.



FIG. 2 illustrates a stabilization device 200 including at least one ‘C’-shaped clip 222 for a catheter fastener of the catheter fasteners 120 in accordance with some embodiments. FIG. 3 illustrates a stabilization device 300 including at least one clamp 322 for a catheter fastener of the catheter fasteners 120 in accordance with some embodiments.


As shown in FIGS. 2 and 3, the catheter fasteners 120 in some embodiments of the stabilization device 100 such as the stabilization devices 200 and 300 are spaced apart from each other to accommodate the extension port 16 of the integrated catheter 10 between the catheter fasteners 120 when the integrated catheter 10 is secured by the catheter fasteners 120 on the platform 110. Between the catheter fasteners 120, the stabilization device 100 optionally includes a hub support 112 configured to support the hub 14 of the integrated catheter 10 between the catheter fasteners 120 when the integrated catheter 10 is secured by the catheter fasteners 120 on the platform 110.


As shown in FIG. 2, at least one catheter fastener of the pair of catheter fasteners 120 of the stabilization device 200 is the ‘C’-shaped clip 222 connected to the catheter-securing side 104 of the platform 110. The ‘C’-shaped clip 222 is configured with a degree of flexibility enabling an opening of the ‘C’-shaped clip to initially expand when the hub 14 of the integrated catheter 10 is inserted into the opening. The ‘C’-shaped clip 222 is configured to subsequently contract when the hub 14 of the integrated catheter 10 is inserted past the opening and seated in the ‘C’-shaped clip 222.


As shown in FIG. 3, at least one catheter fastener of the pair of catheter fasteners 120 of the stabilization device 300 is the clamp 322 having a first jaw 324 connected to the catheter-securing side 104 of the platform 110 and a second jaw 326 connected to the first jaw 324 by a living hinge 325. The clamp 322 is configured with a snap 328 between the first jaw 324 and the second jaw 326 configured to snap the first jaw 324 and the second jaw 326 together when the hub 14 of the integrated catheter 10 is seated into the clamp 322.



FIG. 4 illustrates a first platform (i.e., the platform 110) for the stabilization device 100 in accordance with some embodiments. FIG. 5 illustrates a second platform 510 for the stabilization device 100 in accordance with some embodiments. FIG. 6 illustrates a third platform 610 for the stabilization device 100 in accordance with some embodiments. FIG. 7 illustrates a stabilization device 700 including the platform 510 of FIG. 5 in accordance with some embodiments. FIG. 8 illustrates a stabilization device 800 including the platform 610 of FIG. 6 in accordance with some embodiments.


As shown in FIGS. 4, 5, and 6, each platform of the platforms 110, 510, and 610 includes the transverse axis 412 from which the pair of stabilization wings 130 extend. The transverse axis 412 is an axis of symmetry about which the platform 110, 510, or 610 has twofold rotational symmetry (i.e., C2 symmetry).


As shown in FIG. 5, the platform 510 has a height h2 that is less than a height h1 of the platform 110. Being as the platform 510 is relatively thin and formed of a medically acceptable polymer as described below, the platform 510 is configured with a degree of flexibility enabling the platform 510 to conform to a contour (e.g., a body contour) of a patient at a stabilization site thereof near a percutaneous insertion site for the integrated catheter 10. In contrast, while the platform 110 can be formed of the same polymer as the platform 510, the platform 110 has little to no appreciable flexibility due to the height h1 of the platform 110 being greater than the height h2 of the platform 510. For this reason, the platform 110 is often used with the pad 130, which has a degree of compressibility as described herein. In some embodiments, the platform 510 is also used with the pad 130, thereby increasing conformation of the stabilization device 100 to the contour (e.g., the body contour) of the patient.


The skin-facing side 104 of the platform 510 includes an adhesive (e.g., pressure-sensitive adhesive) thereon configured to adhere to the skin of the patient as with the stabilization device 700 of FIG. 7, from which the adhesive backing 140 is removed for clarity. Alternatively, like the platform 110, the skin-facing side 104 of the platform 510 is adhered to the pad 130, which pad 130, in turn, includes an adhesive (e.g., pressure-sensitive adhesive) on the skin-facing side 104 of the pad 130 configured to adhere to the skin of the patient upon removal of the adhesive backing 140. The adhesive between the pad 130 and the platform 510 that adheres the pad 130 and the platform 510 together can be the same or different then than the adhesive that adheres the stabilization device to the patient.


With respect to the pad 130, the pad 130 of the stabilization device 100 is formed of a medically acceptable foam-like material having a degree of compressibility also enabling the pad 130 to conform to a contour (e.g., a body contour) of a patient at a stabilization site thereof near a percutaneous insertion site for the integrated catheter 10. Again, the skin-facing side 104 of the pad 130 includes an adhesive (e.g., pressure-sensitive adhesive) thereon configured to adhere to the skin of the patient. (See, for example, the stabilization device 200 of FIG. 2, the stabilization device 300 of FIG. 3, or the stabilization device 800 of FIG. 8.)


As shown in FIG. 6, the platform 610 includes a plurality of through holes 612, or breathing holes, configured to enable moisture between, for example, the stabilization device 800 of FIG. 8 and the skin of the patient to escape through the through holes 612 when the stabilization device 800 is adhered to the patient. While not shown, the platform 510 can also include the plurality of through holes 612.


The platform 110, 510, or 610 is formed of a polymeric material such as by injection molding. For example, the platform 510, which is relatively thin and flexible compared to the platform 110, can be formed by injection molding including thin-wall molding. The pair of catheter fasteners 120 can be molded together with the platform 110, 510, or 610 or coupled to the platform 110, 510, or 610 after each of the pair of fasteners 120 and the platform 110, 510, or 610 is molded.


In view of the foregoing description, it should be understood any platform 110, 510, or 610, or a combination thereof, disposed on the pad 130 or not, can include any pair of catheter fasteners 120 described herein to form a stabilization device such as the stabilization device 200, 300, 700, or 800.


Kit


The stabilization device 100, instructions for use of the stabilization device 100, and any one or more additional components selected from the integrated catheter 10, an antimicrobial pad (e.g., BIOPATCH®, GuardIVa®), a topical medicament optionally including an antimicrobial agent, a skin adhesive optionally including an antimicrobial agent, and a degreasing wipe can be packaged as a ready-to-use stabilization kit.


Method


A method for stabilizing integrated catheters such as the integrated catheter 10 includes, in some embodiments, securing the hub 14 of the integrated catheter 10 in the pair of catheter fasteners 120 on the catheter-securing side 104 of the platform 110 of the stabilization device 100, the catheter fasteners 120 spaced apart from each other to accommodate the extension port 16 of the integrated catheter 10 between the catheter fasteners 120; removing an adhesive backing 140 from the skin-facing side 102 of the stabilization device 100 to expose the adhesive; and adhering the stabilization device 100 to skin of the patient at a stabilization site thereof near a percutaneous insertion site, thereby stabilizing the integrated catheter 10 and decreasing risk of mechanical phlebitis.


Securing the hub 14 of the integrated catheter 10 in the pair of catheter fasteners 120 includes expanding the opening of the ‘C’-shaped clip 222 of the pair of catheter fasteners 120 upon inserting the hub 14 into the ‘C’-shaped clip 222 and allowing the opening of the ‘C’-shaped clip 222 to contract upon inserting the hub 14 past the opening of the of the ‘C’-shaped clip 222. Alternatively, securing the hub 14 of the integrated catheter 10 in the pair of catheter fasteners 120 includes enclosing the hub 14 within the clamp 322 of the pair of catheter fasteners 120 and snapping the clamp 322 closed around the hub 14.


The method can further include accessing the percutaneous insertion site in one or more ways of accessing the insertion site such as passing the catheter tube 12 of the integrated catheter 10 into the insertion site.


The method can further include treating the percutaneous insertion site after accessing the insertion site. Treating the insertion site can include placing the antimicrobial pad (e.g., BIOPATCH®, GuardIVa®) around the insertion site to keep the insertion site free of infection. Treating the insertion site can include applying the topical medicament optionally including the antimicrobial agent around the insertion site or sealing the insertion site with the skin adhesive optionally including a same or different antimicrobial agent. Not only does sealing the insertion site with the skin adhesive prevent microbes from entering the insertion site, but sealing the insertion site has the added effect of further stabilizing the integrated catheter 10 to the patient, thereby further decreasing mechanical phlebitis.


The method can further include degreasing the skin of the patient at the stabilization site with a degreasing wipe before adhering the stabilization device 100 to the skin of the patient.


While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications can appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures may be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.

Claims
  • 1. A catheter kit, comprising: an integrated catheter comprising a hub; anda stabilization device, comprising: a platform;first and second stabilization wings extending from a transverse axis of the platform under the platform, the first and second stabilization wings configured to mitigate rotation of the integrated catheter about a longitudinal axis of the integrated catheter when the integrated catheter is secured to the platform;a first catheter fastener positioned on the platform; anda second catheter fastener positioned on the platform disconnected from the first catheter fastener, the first catheter fastener and the second catheter fastener configured to secure the hub of the integrated catheter.
  • 2. The catheter kit according to claim 1, wherein the hub of the integrated catheter includes an extension port coupled to an extension tube.
  • 3. The catheter kit according to claim 2, wherein the first catheter fastener is separated from the second catheter fastener a sufficient distance to accommodate the extension port of the hub of the integrated catheter.
  • 4. The catheter kit according to claim 1, wherein the platform is configured with a degree of flexibility enabling the platform to conform to a contour of a patient at a stabilization site.
  • 5. The catheter kit according to claim 1, wherein the platform includes an adhesive configured to adhere to skin of a patient.
  • 6. The catheter kit according to claim 1, wherein the stabilization device further comprises a pad formed of a compressible material to enable the pad to conform to a contour of a patient at a stabilization site.
  • 7. The catheter kit according to claim 6, wherein the pad comprises an adhesive configured to adhere to skin of the patient.
  • 8. The catheter kit according to claim 1, wherein the first catheter fastener is a ‘C’-shaped clip connected to the platform.
  • 9. The catheter kit according to claim 8, wherein the ‘C’-shaped clip is configured with a degree of flexibility enabling an opening of the ‘C’-shaped clip to initially expand when the hub of the integrated catheter is inserted into the opening and to subsequently contract when the hub of the integrated catheter is inserted past the opening.
  • 10. The catheter kit according to claim 1, wherein at least one of the first catheter fastener and the second catheter fastener is a clamp having a first jaw connected to the platform and a second jaw connected to the first jaw by a living hinge.
  • 11. The catheter kit according to claim 10, wherein the clamp is configured with a snap between the first jaw and the second jaw configured to snap the first jaw and the second jaw together after the hub of the integrated catheter is inserted into the clamp.
  • 12. The catheter kit according to claim 1, wherein the transverse axis of the platform is an axis of symmetry of the platform.
  • 13. The catheter kit according to claim 1, wherein the platform has twofold symmetry about the transverse axis of the platform.
  • 14. The catheter kit according to claim 1, wherein the platform is formed of a polymer material.
  • 15. The catheter kit according to claim 1, wherein the platform includes a plurality of through holes configured to enable moisture to escape through the plurality of through holes when the stabilization device is adhered to a patient.
PRIORITY

This application is a continuation of U.S. patent application Ser. No. 16/825,834, filed Mar. 20, 2020, now U.S. Pat. No. 11,426,557, which claims the benefit of priority to U.S. Provisional Application No. 62/822,721, filed Mar. 22, 2019, each of which is incorporated by reference in its entirety into this application.

US Referenced Citations (299)
Number Name Date Kind
6663600 Bierman et al. Dec 2003 B2
6673046 Bierman et al. Jan 2004 B2
6689104 Bierman Feb 2004 B2
6796310 Bierman Sep 2004 B2
6827705 Bierman Dec 2004 B2
6827707 Wright et al. Dec 2004 B2
6866652 Bierman Mar 2005 B2
6929625 Bierman Aug 2005 B2
6948500 Bierman Sep 2005 B2
6951550 Bierman Oct 2005 B2
6972003 Bierman et al. Dec 2005 B2
6979320 Bierman Dec 2005 B2
7014627 Bierman Mar 2006 B2
7018362 Bierman et al. Mar 2006 B2
7153291 Bierman Dec 2006 B2
7204827 Kessler Apr 2007 B2
7223256 Bierman May 2007 B2
7247150 Bierman Jul 2007 B2
7354421 Bierman Apr 2008 B2
7491190 Bierman et al. Feb 2009 B2
7520870 Bierman Apr 2009 B2
7563251 Bierman et al. Jul 2009 B2
7568484 Bierman et al. Aug 2009 B2
7578804 Bierman Aug 2009 B2
7591803 Bierman Sep 2009 B2
7628154 Bierman et al. Dec 2009 B2
7628771 Kessler Dec 2009 B2
7635355 Bierman Dec 2009 B2
7648492 Bierman Jan 2010 B2
7651479 Bierman Jan 2010 B2
7666167 Bierman Feb 2010 B2
7722571 Bierman et al. May 2010 B2
7744572 Bierman Jun 2010 B2
7762991 Bierman et al. Jul 2010 B2
7785295 Bierman Aug 2010 B2
7799001 Bierman Sep 2010 B2
7806873 Dikeman et al. Oct 2010 B2
7811258 Bierman Oct 2010 B2
7837655 Bierman et al. Nov 2010 B2
7879013 Smith et al. Feb 2011 B2
7887515 Bierman Feb 2011 B2
7935083 Bierman et al. May 2011 B2
7935084 Bierman May 2011 B2
7955307 Bierman et al. Jun 2011 B2
7967792 Bierman Jun 2011 B2
7972310 Kessler Jul 2011 B2
7985206 Dikeman et al. Jul 2011 B2
7988673 Wright et al. Aug 2011 B2
8016792 Wright et al. Sep 2011 B2
8016793 Wright et al. Sep 2011 B2
8025060 Bierman Sep 2011 B2
8025643 Bierman Sep 2011 B2
8043280 Bierman Oct 2011 B2
8052648 Dikeman et al. Nov 2011 B2
8052649 Wright Nov 2011 B2
8052652 Bierman et al. Nov 2011 B2
8057440 Bierman Nov 2011 B2
8074651 Bierman et al. Dec 2011 B2
8100862 Bierman Jan 2012 B2
8105289 Bierman et al. Jan 2012 B2
8105290 Wright et al. Jan 2012 B2
8114054 Bierman et al. Feb 2012 B2
8146210 Nishtala Apr 2012 B2
8162898 Wright Apr 2012 B1
8172807 Dikeman et al. May 2012 B2
8177756 Wright May 2012 B2
8197447 Wright Jun 2012 B2
8211063 Bierman et al. Jul 2012 B2
8241253 Bracken Aug 2012 B2
8246583 Bierman Aug 2012 B2
8251956 Bierman et al. Aug 2012 B2
8269059 Wright et al. Sep 2012 B2
8277420 Bierman et al. Oct 2012 B2
8282606 Bierman Oct 2012 B2
8298191 Bierman et al. Oct 2012 B2
8333736 Wright et al. Dec 2012 B2
8357124 Bierman Jan 2013 B2
8366678 Bierman et al. Feb 2013 B2
8394065 Bierman Mar 2013 B2
8394067 Bracken et al. Mar 2013 B2
8398599 Bierman Mar 2013 B2
8465458 Bierman Jun 2013 B2
8506531 Bierman Aug 2013 B2
8540680 Burn Sep 2013 B2
8585655 Bierman Nov 2013 B2
8608704 Bierman Dec 2013 B2
8608705 Peters et al. Dec 2013 B2
8636698 Bierman et al. Jan 2014 B2
8636701 Henry et al. Jan 2014 B2
8641678 Bierman Feb 2014 B2
8657791 Bierman et al. Feb 2014 B2
8679066 Aviles Mar 2014 B2
8679067 Wright Mar 2014 B2
8684976 Bierman et al. Apr 2014 B2
8708967 Bierman Apr 2014 B2
8728039 Bierman et al. May 2014 B2
8734400 Ciccone May 2014 B2
8740852 Aviles Jun 2014 B2
8827959 Wright et al. Sep 2014 B2
8834424 Parvatiyar et al. Sep 2014 B2
8834425 Bracken et al. Sep 2014 B2
8840589 Bierman et al. Sep 2014 B2
8900196 Andino Dec 2014 B2
8915885 Smith et al. Dec 2014 B2
9017290 Peters et al. Apr 2015 B2
9056186 Wright et al. Jun 2015 B2
9061122 Bierman et al. Jun 2015 B2
9067013 Wright et al. Jun 2015 B2
9138560 Wright et al. Sep 2015 B2
9415191 Aviles Aug 2016 B2
9468740 Bierman et al. Oct 2016 B2
9480821 Ciccone et al. Nov 2016 B2
9526871 Wright et al. Dec 2016 B2
9561348 Bierman Feb 2017 B2
9604034 Andino Mar 2017 B2
9616200 Smith et al. Apr 2017 B2
9642987 Bierman et al. May 2017 B2
9694130 Andino et al. Jul 2017 B2
9700700 Andino et al. Jul 2017 B2
9731097 Andino et al. Aug 2017 B2
9962524 Andino May 2018 B2
9974929 Ciccone et al. May 2018 B2
9993619 Bracken et al. Jun 2018 B2
10245415 Andino et al. Apr 2019 B2
10322262 Bracken et al. Jun 2019 B2
10426928 Andino et al. Oct 2019 B2
10537714 Andino et al. Jan 2020 B2
10561815 Bierman et al. Feb 2020 B2
10589067 Ciccone Mar 2020 B2
10729887 Andino et al. Aug 2020 B2
11020565 Spitler Jun 2021 B2
11420023 Andino et al. Aug 2022 B2
11426557 Naidu Aug 2022 B2
20020068904 Bierman et al. Jun 2002 A1
20020133121 Bierman Sep 2002 A1
20020165493 Bierman Nov 2002 A1
20020165494 Bierman et al. Nov 2002 A1
20020187259 Bierman Dec 2002 A1
20020188255 Bierman et al. Dec 2002 A1
20020188257 Bierman Dec 2002 A1
20030083625 Bierman May 2003 A1
20030089374 Bierman May 2003 A1
20030125668 Bierman Jul 2003 A1
20030229313 Bierman Dec 2003 A1
20040034330 Bierman et al. Feb 2004 A1
20040102736 Bierman May 2004 A1
20040138624 Bierman Jul 2004 A1
20040167475 Wright et al. Aug 2004 A1
20040199122 Bierman et al. Oct 2004 A1
20040204684 Bierman Oct 2004 A1
20040226565 Bierman Nov 2004 A1
20050010173 Bierman et al. Jan 2005 A1
20050027258 Bierman et al. Feb 2005 A1
20050075610 Bierman Apr 2005 A1
20050131351 Bierman Jun 2005 A1
20050192539 Bierman et al. Sep 2005 A1
20050192540 Kessler Sep 2005 A1
20050263158 Bierman Dec 2005 A1
20050273058 Bierman Dec 2005 A1
20060064063 Bierman Mar 2006 A1
20060089600 Bierman et al. Apr 2006 A1
20060124133 Bierman et al. Jun 2006 A1
20060129103 Bierman et al. Jun 2006 A1
20060135944 Bierman Jun 2006 A1
20060184127 Bierman Aug 2006 A1
20060184128 Bierman Aug 2006 A1
20060184129 Bierman Aug 2006 A1
20060247577 Wright Nov 2006 A1
20060264836 Bierman Nov 2006 A1
20060270994 Bierman Nov 2006 A1
20060270995 Bierman Nov 2006 A1
20060276752 Bierman et al. Dec 2006 A1
20070055205 Wright et al. Mar 2007 A1
20070066958 Wright Mar 2007 A1
20070068533 Bierman et al. Mar 2007 A1
20070088329 Bierman Apr 2007 A1
20070142784 Dikeman et al. Jun 2007 A1
20070149930 Bierman Jun 2007 A1
20070156097 Bierman Jul 2007 A1
20070167915 Bierman Jul 2007 A1
20070173766 Bierman Jul 2007 A1
20070173769 Kessler Jul 2007 A1
20070219500 Wright et al. Sep 2007 A1
20070265572 Smith et al. Nov 2007 A1
20070276332 Bierman Nov 2007 A1
20070276333 Bierman Nov 2007 A1
20070276334 Bierman et al. Nov 2007 A1
20070276335 Bierman Nov 2007 A1
20070276336 Bierman et al. Nov 2007 A1
20070282273 Bierman Dec 2007 A1
20070287963 Bierman Dec 2007 A1
20080027391 Bierman Jan 2008 A1
20080027392 Bierman Jan 2008 A1
20080027393 Bierman Jan 2008 A1
20080027394 Bierman Jan 2008 A1
20080039798 Bierman Feb 2008 A1
20080077118 Bierman Mar 2008 A1
20080097334 Dikeman et al. Apr 2008 A1
20080132848 Wright et al. Jun 2008 A1
20080154208 Bierman Jun 2008 A1
20080249476 Bierman et al. Oct 2008 A1
20090036835 Bierman Feb 2009 A1
20090043260 Bierman Feb 2009 A1
20090093766 Bierman et al. Apr 2009 A1
20090093769 Wright et al. Apr 2009 A1
20090137961 Bracken May 2009 A1
20090137962 Bracken et al. May 2009 A1
20090139061 Nishtala Jun 2009 A1
20090143740 Bierman et al. Jun 2009 A1
20090143741 Bum Jun 2009 A1
20090143742 Bracken et al. Jun 2009 A1
20090143744 Bierman et al. Jun 2009 A1
20090145440 Bierman et al. Jun 2009 A1
20090182283 Sloan Jul 2009 A1
20090254040 Bierman et al. Oct 2009 A1
20090259188 Bierman et al. Oct 2009 A1
20090306603 Bierman et al. Dec 2009 A1
20090326474 Bierman et al. Dec 2009 A1
20100022962 Bierman et al. Jan 2010 A1
20100100051 Bierman Apr 2010 A1
20100114034 Wright et al. May 2010 A1
20100137807 Kessler Jun 2010 A1
20100179481 Bierman et al. Jul 2010 A1
20100179482 Wright et al. Jul 2010 A1
20100179483 Wright et al. Jul 2010 A1
20100180900 Talsma et al. Jul 2010 A1
20100222748 Bierman et al. Sep 2010 A1
20100298777 Nishtala Nov 2010 A1
20100298778 Bracken et al. Nov 2010 A1
20100324491 Bierman et al. Dec 2010 A1
20110021998 Dikeman et al. Jan 2011 A1
20110054409 Nishtala Mar 2011 A1
20110112483 Smith et al. May 2011 A1
20110178467 Bierman et al. Jul 2011 A1
20110202010 Bierman Aug 2011 A1
20110213310 Bierman Sep 2011 A1
20110218498 Bierman et al. Sep 2011 A1
20110230843 Bierman et al. Sep 2011 A1
20110240034 Ciccone Oct 2011 A1
20110245777 Andino et al. Oct 2011 A1
20110257600 Kessler Oct 2011 A1
20110264050 Henry et al. Oct 2011 A1
20110282291 Ciccone Nov 2011 A1
20110282294 Dikeman et al. Nov 2011 A1
20110288487 Wright et al. Nov 2011 A1
20110288489 Bierman et al. Nov 2011 A1
20110295173 Wright et al. Dec 2011 A1
20110295210 Wright Dec 2011 A1
20110313362 Bierman Dec 2011 A1
20110319830 Peters et al. Dec 2011 A1
20120029484 Gusmao et al. Feb 2012 A1
20120041378 Bierman Feb 2012 A1
20120046649 Bierman Feb 2012 A1
20120053526 Bierman et al. Mar 2012 A1
20120059328 Dikeman et al. Mar 2012 A1
20120059329 Bierman Mar 2012 A1
20120123343 Aviles May 2012 A1
20120136314 Ciccone et al. May 2012 A1
20120143140 Bierman et al. Jun 2012 A1
20120150117 Andino Jun 2012 A1
20120184915 Bierman et al. Jul 2012 A1
20120197202 Wright et al. Aug 2012 A1
20120197205 Peters Aug 2012 A1
20120215173 Wright Aug 2012 A1
20120220947 Dikeman et al. Aug 2012 A1
20120232488 Aviles Sep 2012 A1
20120232490 Andino Sep 2012 A1
20120265147 Andino et al. Oct 2012 A1
20120271237 Andino Oct 2012 A1
20120271239 Andino et al. Oct 2012 A1
20120271240 Andino et al. Oct 2012 A1
20120316505 Wright Dec 2012 A1
20130018322 Wright et al. Jan 2013 A1
20130053785 Parvatiyar et al. Feb 2013 A1
20130079723 Andino et al. Mar 2013 A1
20130138045 Bierman May 2013 A1
20130138080 Andino et al. May 2013 A1
20130150827 Bracken et al. Jun 2013 A1
20130345639 Spittler Dec 2013 A1
20140188078 Peters et al. Jul 2014 A1
20140249478 Bierman et al. Sep 2014 A1
20140276542 Ciccone Sep 2014 A1
20140276544 Aviles Sep 2014 A1
20140343501 Bierman et al. Nov 2014 A1
20150088076 Andino Mar 2015 A1
20150112270 Smith et al. Apr 2015 A1
20150367102 Andino et al. Dec 2015 A1
20160008577 Wright et al. Jan 2016 A1
20170043131 Ciccone et al. Feb 2017 A1
20170216556 Bierman et al. Aug 2017 A1
20170296788 Andino et al. Oct 2017 A1
20170296789 Andino et al. Oct 2017 A1
20190247625 Bracken et al. Aug 2019 A1
20200030578 Andino et al. Jan 2020 A1
20200171273 Bierman et al. Jun 2020 A1
20200215309 Ciccone Jul 2020 A1
20200297975 Naidu Sep 2020 A1
20200324085 Andino et al. Oct 2020 A1
20210283375 Spitler Sep 2021 A1
Foreign Referenced Citations (2)
Number Date Country
2264219 Dec 2006 ES
2015134250 Sep 2015 WO
Non-Patent Literature Citations (4)
Entry
PCT/US2020/024010 filed Mar. 20, 2020 International Search Report and Written Opinion dated Jun. 2, 2020.
uS16/825,834 filed Mar. 20, 2020 Non-Final Office Action dated Nov. 4, 2021.
uS16/825,834 filed Mar. 20, 2020 Notice of Allowance dated Apr. 13, 2022.
EP 207797853 filed Sep. 30, 2021 Extended European Search Report dated Nov. 21, 2022.
Related Publications (1)
Number Date Country
20220409862 A1 Dec 2022 US
Provisional Applications (1)
Number Date Country
62822721 Mar 2019 US
Continuations (1)
Number Date Country
Parent 16825834 Mar 2020 US
Child 17898337 US